Home » Topics » BioWorld Science

BioWorld Science
RSS

Roche and Genentech prepare prodrugs of fibrinogen antagonist

Sep. 6, 1996

Bayer's new cGMP PDE inhibitors

Sep. 6, 1996

Hisamitsu describes platelet aggregation inhibitors

Sep. 6, 1996

Thalidomide derivatives as leads for septic shock therapy

Sep. 6, 1996

Arginine analogues for shock

Sep. 6, 1996

E. Merck describes cardioactive agents

Sep. 6, 1996

Genentech claims CHF for heart failure and neurological disorders

Sep. 6, 1996

cGMP PDE inhibitors from Taisho

Sep. 6, 1996

Clinical trials to begin on laser for transmyocardial revascularization

Sep. 6, 1996

Generic nadolol approved

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...